Physician profile
Thomas Ray
NPI 1477662286
$1,741.05
in general payments reported to CMS, 2019-2025
10 companies · $16.93 in 2025
The $16.93 reported for 2025 was less than what a typical Nurse Anesthetist, Certified Registered provider received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $345 · 2022: $491 · 2023: $516 · 2024: $372 · 2025: $16.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $905.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $651.77 | 2021-2024 | Xifaxan, Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $437.77 | 2021-2023 | Entyvio, Gattex |
| Regeneron Healthcare Solutions, INC. | $168.79 | 2022-2024 | Dupixent |
| Intercept Pharmaceuticals, INC. | $161.60 | 2022-2024 | Ocaliva |
| Merck Sharp & Dohme LLC | $114.73 | 2021-2025 | Dificid, Zerbaxa, Bridion |
| Janssen Biotech, INC. | $78.56 | 2024 | Tremfya, Stelara |
| Abbvie INC. | $45.96 | 2021 | |
| Redhill Biopharma INC. | $38.67 | 2023 | Aemcolo, Talicia, Movantik |
| Ironwood Pharmaceuticals, INC | $26.61 | 2024 | |
| Kci USA, INC. | $16.59 | 2023 | Prevena Restor Arthroform |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.